NDA SUPPLEMENTS FOR CHANGES IN ROUTE OF DRUG SYNTHESIS MUST BE PREAPPROVED BY FDA; PURITY CONCERNS MAY REQUIRE IN VIVO TESTING, AGENCY SAYS IN NDA REWRITE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".